Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Range Impact GAAP EPS of $0.05, revenue of $0.7M | 3 | Seeking Alpha | ||
Do | Range Impact, Inc.: Range Impact Reports 1Q 2025 Financial Results | 35 | GlobeNewswire (Europe) | Cleveland, Ohio, May 15, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
02.04. | Range Impact, Inc.: Range Impact Announces Major Land Acquisition in West Virginia | 74 | GlobeNewswire (Europe) | CLEVELAND, OHIO, April 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen | |
02.04. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
23.01. | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
19.12.24 | RANGE IMPACT, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
04.12.24 | RANGE IMPACT, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
07.10.24 | Range Impact, Inc.: Range Impact Announces Uplisting to the OTCQB Venture Market | 177 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and... ► Artikel lesen | |
RANGE IMPACT Aktie jetzt für 0€ handeln | |||||
02.10.24 | Range Impact, Inc.: Range Impact Announces Sale of Cannabinoid Drug Development Business | 154 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and the... ► Artikel lesen | |
29.08.24 | Range Impact, Inc.: Range Impact Announces Sale of Non-Core Assets as Part of Strategic Plan | 269 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and the... ► Artikel lesen | |
14.08.24 | Range Impact, Inc.: Range Impact Reports 2Q 2024 Financial Results | 378 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact"), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 57,69 | -2,65 % | Amazon, Deutsche Telekom, Deutz, Novo Nordisk, Rheinmetall, Smartbroker - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
AURORA CANNABIS | 4,600 | +3,84 % | BRISANTE Meldung setzt Aurora Cannabis Aktionäre unter Zugzwang. Bitte reagieren Sie jetzt sofort! | ||
CANOPY GROWTH | 1,486 | +24,66 % | Starke Zahlen, Aktie steigt: Nicht Canopy Growth: Diese Cannabis-Aktie gibt es jetzt umsonst! | © Foto: Dall-EDas Cannabisunternehmen Cronos hat am Donnerstagmittag starke Quartalszahlen vorgelegt - und im Unterschied zu Canopy Growth einen Nettogewinn erzielt.Innerhalb der Cannabis-Branche gilt... ► Artikel lesen | |
TILRAY BRANDS | 0,434 | +10,49 % | Schock-News für Tilray Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
VERTEX PHARMACEUTICALS | 388,80 | +0,12 % | VERTEX PHARMACEUTICALS INC / MA - 8-K, Current Report | ||
TAAT GLOBAL ALTERNATIVES | 0,111 | 0,00 % | XFRA 2TP0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILTAAT GLOBAL ALTERNAT.... ► Artikel lesen | |
CRONOS GROUP | 1,891 | +1,39 % | Cronos Group Inc.: Cronos Group Reports 2025 First Quarter Results | Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 5,376 | +5,21 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
ORGANIGRAM GLOBAL | 1,160 | +3,57 % | Buy Organigram for big returns, Haywood says | ||
GREEN THUMB INDUSTRIES | 5,000 | -2,25 % | Green Thumb Industries should be a core holding for cannabis investors, analyst says | ||
MYDECINE INNOVATIONS GROUP | 0,009 | 0,00 % | Aquis Stock Exchange: Withdrawal from Trading - Mydecine Innovations Group Inc. | Aquis Stock Exchange
Aquis Stock Exchange: Withdrawal from Trading 02-Apr-2025 / 07:00 GMT/BST
The issuer is solely responsible for the content of this... ► Artikel lesen | |
ASTRIA THERAPEUTICS | 3,820 | +7,30 % | JMP cuts Astria Therapeutics target to $25, maintains rating | ||
SANTHERA PHARMACEUTICALS | 13,680 | -1,16 % | XFRA NEW INSTRUMENTS AVAILABLE ON 02.05.2025 | The following instruments on XETRA do have their first trading 02.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.05.2025
Aktien
1 CH0432492467 Alcon AG 2U3
2 CH0110240600... ► Artikel lesen | |
TONIX PHARMACEUTICALS | 26,600 | +29,13 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights | FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Announced... ► Artikel lesen |